These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 7550860)
1. Effects of short-term administration of the CCK receptor antagonist, KSG-504, on regeneration of pancreatic acinar cells in acute pancreatitis in rats. Okumura Y; Inoue H; Fujiyama Y; Bamba T J Gastroenterol; 1995 Aug; 30(4):493-9. PubMed ID: 7550860 [TBL] [Abstract][Full Text] [Related]
2. [Effect of KSG-504, a new synthetic cholecystokinin receptor antagonist on ethionine-induced acute pancreatitis in rats]. Okumura Y; Bamba T; Shintani Y; Yoshioka U; Inoue H; Fujiyama Y; Hosoda S Nihon Shokakibyo Gakkai Zasshi; 1993 Dec; 90(12):3032-40. PubMed ID: 8283814 [TBL] [Abstract][Full Text] [Related]
3. [Effect of KSG-504, a new CCK-A-receptor antagonist, on experimental acute pancreatitis in rats and mice]. Kobayashi M; Shinagawa K; Sugiura M; Nagasawa T; Akahane M; Ajisawa Y Nihon Yakurigaku Zasshi; 1996 Apr; 107(4):183-95. PubMed ID: 8690301 [TBL] [Abstract][Full Text] [Related]
4. A new CCK-A antagonist, KSG-504, administered intraduodenally, inhibits pancreatic secretion in rats. Moriyoshi Y; Shiratori K; Takeuchi T; Watanabe S Pancreas; 1994 Mar; 9(2):225-9. PubMed ID: 8190724 [TBL] [Abstract][Full Text] [Related]
5. Different inhibitory effects of the newly developed CCK receptor antagonists FK480 and KSG-504 on pancreatic exocrine and endocrine secretion in the isolated perfused rat pancreas. Kihara Y; Otsuki M Pancreas; 1995 Mar; 10(2):109-17. PubMed ID: 7716133 [TBL] [Abstract][Full Text] [Related]
6. Effects of KSG-504, a new cholecystokinin-A-receptor antagonist, on pancreatic exocrine and endocrine secretions in rats. Yamazaki Y; Akahane M; Kobayashi M; Takeda H; Ajisawa Y Jpn J Pharmacol; 1996 Feb; 70(2):183-90. PubMed ID: 8866756 [TBL] [Abstract][Full Text] [Related]
7. Cytokine level changes in L-arginine-induced acute pancreatitis in rat. Takács T; Czakó L; Jármay K; Farkas G; Mándi Y; Lonovics J Acta Physiol Hung; 1996; 84(2):147-56. PubMed ID: 9046361 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of KSG-504, a new cholecystokinin-A-receptor antagonist. Yamazaki Y; Akahane M; Kobayashi M; Kitazawa M; Kurashina Y; Iizuka K Jpn J Pharmacol; 1993 Oct; 63(2):219-25. PubMed ID: 7506805 [TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin-A specific antagonism of KSG-504 to cholecystokinin receptor binding and pancreatic secretion in mammals. Yamazaki Y; Shinagawa K; Takeda H; Kobayashi M; Akahane M; Ajisawa Y Jpn J Pharmacol; 1995 Dec; 69(4):367-73. PubMed ID: 8786640 [TBL] [Abstract][Full Text] [Related]
10. Effect of a new cholecystokinin receptor antagonist (KSG 504) on the early stage of the healing process in acute pancreatitis induced in rats by the closed duodenal loop technique. Ha S; Satake K; Hiura A; Sowa M; Nishiwaki H Pancreas; 1994 Jul; 9(4):501-7. PubMed ID: 7524065 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic regeneration after ethionine-induced acute pancreatitis in rats lacking pancreatic CCK-A receptor gene expression. Sato T; Niikawa J; Usui I; Imamura T; Yoshida H; Tanaka S; Mitamura K J Gastroenterol; 2003; 38(7):672-80. PubMed ID: 12898360 [TBL] [Abstract][Full Text] [Related]
12. The pathogenesis of L-arginine-induced acute necrotizing pancreatitis: inflammatory mediators and endogenous cholecystokinin. Czakó L; Takács T; Varga IS; Hai DQ; Tiszlavicz L; Hegyi P; Mándi Y; Matkovics B; Lonovics J J Physiol Paris; 2000; 94(1):43-50. PubMed ID: 10761688 [TBL] [Abstract][Full Text] [Related]
13. CCK administration after CCK receptor blockade accelerates recovery from cerulein-induced acute pancreatitis in rats. Nakano S; Kihara Y; Otsuki M Pancreas; 1998 Mar; 16(2):169-75. PubMed ID: 9510141 [TBL] [Abstract][Full Text] [Related]
14. [Effects of KSG-504, a new CCK-A receptor antagonist, on gallbladder and gastrointestinal functions]. Yamazaki Y; Akahane M; Kobayashi M; Shinagawa K; Sugiura M; Ajisawa Y Nihon Yakurigaku Zasshi; 1996 Jan; 107(1):33-44. PubMed ID: 8720296 [TBL] [Abstract][Full Text] [Related]
15. [Behavioral studies of KSG-504, a new CCK-A receptor antagonist]. Yamazaki Y; Takeda H; Akahane M; Tsubaki A; Ajisawa Y Nihon Yakurigaku Zasshi; 1996 Jan; 107(1):21-31. PubMed ID: 8720295 [TBL] [Abstract][Full Text] [Related]
16. Effect of the cholecystokinin receptor antagonist loxiglumide on pancreatic exocrine function in rats after acute pancreatitis. Nakano S; Tachibana I; Otsuki M Pancreas; 1995 Apr; 10(3):287-94. PubMed ID: 7542770 [TBL] [Abstract][Full Text] [Related]
17. Role of endogenous cholecystokinin in the regeneration of pancreatic tissue after acute hemorrhagic pancreatitis in rats. Song W; Yamaguchi H; Nakano I; Kimura T; Nawata H Fukuoka Igaku Zasshi; 1996 Jan; 87(1):14-22. PubMed ID: 8820983 [TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin-1 receptor protein up-regulation during pancreatic regeneration after acute haemorrhagic pancreatitis in rats. Yoshikawa H; Nakamura H; Tashiro M; Yamaguchi T; Taguchi M; Fukumitsu K; Otsuki M Eur J Clin Invest; 2004 Jul; 34(7):498-507. PubMed ID: 15255787 [TBL] [Abstract][Full Text] [Related]
19. Involvement of endogenous cholecystokinin in pancreatic regeneration after cerulein-induced acute pancreatitis. Jurkowska G; Grondin G; Morisset J Pancreas; 1992; 7(3):295-304. PubMed ID: 1594550 [TBL] [Abstract][Full Text] [Related]
20. Effects of early decompression and cholecystokinin inhibition in rats with acute pancreatitis induced by bile-pancreatic-duct obstruction. de Dios I; Urunuela A; Manso M J Lab Clin Med; 2003 Apr; 141(4):265-71. PubMed ID: 12677172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]